# Eiger BioPharmaceuticals Inc. (EIGR)

Source: https://www.quantisnow.com/company/EIGR
Generated: 2026-11-06T14:27:46.907Z

- Ticker: EIGR
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Biotechnology: Biological Products (No Diagnostic Substances)
- IPO year: 2014
- Website: eigerbio.com

## About

Eiger BioPharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of targeted therapies for rare and ultra-rare diseases in the United States and internationally. Its lead product candidate is Lonafarnib, an orally bioavailable, small molecule, which is in Phase III clinical trials to treat hepatitis delta virus infection. The company's product candidate also include Lambda, which targets type III interferon receptors that has completed Phase II clinical trials; Lonafarnib for the treatment of progeria and progeroid laminopathies; and Avexitide for the treatment of congenital hyperinsulinism, as well as has completed Phase II clinical trials to treat post-bariatric hypoglycemia. The company was founded in 2008 and is headquartered in Palo Alto, California.

## Latest EIGR news and filings

- 2024-05-10 18:14 UTC [SEC Schedule 13G] [SEC Form SC 13G/A filed by Eiger BioPharmaceuticals Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13ga-filed-by-eiger-biopharmaceuticals-inc-amendment-5481319)
- 2024-05-08 21:00 UTC [SEC Form 8-K] [SEC Form 8-K filed by Eiger BioPharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-8-k-filed-by-eiger-biopharmaceuticals-inc-5473394)
- 2024-05-02 20:32 UTC [SEC Form 8-K] [SEC Form 8-K filed by Eiger BioPharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-8-k-filed-by-eiger-biopharmaceuticals-inc-5455127)
- 2024-04-29 20:33 UTC [SEC Form 10-K] [SEC Form 10-K/A filed by Eiger BioPharmaceuticals Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-10-ka-filed-by-eiger-biopharmaceuticals-inc-amendment-5441688)
- 2024-04-08 21:19 UTC [SEC Form 10-K] [SEC Form 10-K filed by Eiger BioPharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-10-k-filed-by-eiger-biopharmaceuticals-inc-5398461)
- 2024-04-04 20:31 UTC [Market Insight] [12 Health Care Stocks Moving In Thursday's After-Market Session](https://www.quantisnow.com/insight/12-health-care-stocks-moving-in-thursdays-after-market-session-5393105)
- 2024-04-04 17:21 UTC [Market Insight] [Why STAAR Surgical Shares Are Trading Higher By Around 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session](https://www.quantisnow.com/insight/why-staar-surgical-shares-are-trading-higher-by-around-13-5392433)
- 2024-04-04 16:31 UTC [Market Insight] [12 Health Care Stocks Moving In Thursday's Intraday Session](https://www.quantisnow.com/insight/12-health-care-stocks-moving-in-thursdays-intraday-session-5392326)
- 2024-04-04 11:58 UTC [Market Insight] [Why Flora Growth Shares Are Trading Lower By Around 20%; Here Are 20 Stocks Moving Premarket](https://www.quantisnow.com/insight/why-flora-growth-shares-are-trading-lower-by-around-20-5391367)
- 2024-04-03 20:49 UTC [Market Chatter] [Eiger Biopharmaceuticals Says On April 2, Received Notice From Nasdaq That Co's Common Stock Will Be Delisted From Nasdaq; Common Stock Is Expected To Begin Trading On Over-Counter Market On April 11](https://www.quantisnow.com/insight/eiger-biopharmaceuticals-says-on-april-2-received-notice-from-nasdaq-5389552)
- 2024-04-03 20:45 UTC [SEC Form 8-K] [SEC Form 8-K filed by Eiger BioPharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-8-k-filed-by-eiger-biopharmaceuticals-inc-5389500)
- 2024-04-03 20:31 UTC [Market Insight] [12 Health Care Stocks Moving In Wednesday's After-Market Session](https://www.quantisnow.com/insight/12-health-care-stocks-moving-in-wednesdays-after-market-session-5389199)
- 2024-04-01 21:00 UTC [SEC Form NT 10-K filed by Eiger BioPharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-nt-10-k-filed-by-eiger-biopharmaceuticals-inc-5381646)
- 2024-04-01 20:58 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Eiger BioPharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-eiger-biopharmaceuticals-inc-5381593)
- 2024-04-01 20:55 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Eiger BioPharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-eiger-biopharmaceuticals-inc-5381577)
- 2024-04-01 20:56 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Eiger BioPharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-eiger-biopharmaceuticals-inc-5381564)
- 2024-04-01 20:53 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Eiger BioPharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-eiger-biopharmaceuticals-inc-5381545)
- 2024-04-01 20:54 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Eiger BioPharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-eiger-biopharmaceuticals-inc-5381541)
- 2024-04-01 20:51 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Eiger BioPharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-eiger-biopharmaceuticals-inc-5381522)
- 2024-04-01 20:50 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Eiger BioPharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-eiger-biopharmaceuticals-inc-5381512)
- 2024-04-01 20:48 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Eiger BioPharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-eiger-biopharmaceuticals-inc-5381492)
- 2024-04-01 20:48 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Eiger BioPharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-eiger-biopharmaceuticals-inc-5381472)
- 2024-04-01 20:45 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Eiger BioPharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-eiger-biopharmaceuticals-inc-5381449)
- 2024-04-01 20:45 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Eiger BioPharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-eiger-biopharmaceuticals-inc-5381446)
- 2024-04-01 20:18 UTC [SEC Form 8-K] [Eiger BioPharmaceuticals Inc. filed SEC Form 8-K: Bankruptcy or Receivership](https://www.quantisnow.com/insight/eiger-biopharmaceuticals-inc-filed-sec-form-8-k-bankruptcy-or-receivership-5380993)
- 2024-04-01 18:31 UTC [Market Insight] [Why Nuvve Holding Shares Are Trading Lower By Around 30%? Here Are Other Stocks Moving In Monday's Mid-Day Session](https://www.quantisnow.com/insight/why-nuvve-holding-shares-are-trading-lower-by-around-30-5380343)
- 2024-04-01 17:43 UTC [Market Insight] [Metabolic Diseases-Focused Eiger BioPharmaceuticals Files For Bankruptcy, Stock Nosedives](https://www.quantisnow.com/insight/metabolic-diseases-focused-eiger-biopharmaceuticals-files-for-bankruptcy-stock-nosedives-5380252)
- 2024-04-01 16:31 UTC [Market Insight] [12 Health Care Stocks Moving In Monday's Intraday Session](https://www.quantisnow.com/insight/12-health-care-stocks-moving-in-mondays-intraday-session-5380089)
- 2024-04-01 15:22 UTC [Market Chatter] [Eiger BioPharmaceuticals shares are trading lower after the company announced it filed for voluntary Chapter 11 protection.](https://www.quantisnow.com/insight/eiger-biopharmaceuticals-shares-are-trading-lower-after-the-company-announced-5379923)
- 2024-04-01 15:20 UTC [Market Chatter] [Eiger BioPharmaceuticals Shares Resume Trade Following Circuit Breaker Halt, Stock Now Down -55.6%](https://www.quantisnow.com/insight/eiger-biopharmaceuticals-shares-resume-trade-following-circuit-breaker-halt-stock-5379917)
- 2024-04-01 15:16 UTC [Market Chatter] [Eiger BioPharmaceuticals Files For Voluntary Chapter 11 Protection; Announces "Stalking Horse" Agreement For The Sale Of Zokinvy To Sentynl Therapeutics For Up To $26M; Access To Zokinvy To Continue Uninterrupted](https://www.quantisnow.com/insight/eiger-biopharmaceuticals-files-for-voluntary-chapter-11-protection-announces-stalking-5379911)
- 2024-04-01 15:12 UTC [Eiger BioPharmaceuticals Files for Voluntary Chapter 11 Protection](https://www.quantisnow.com/insight/eiger-biopharmaceuticals-files-for-voluntary-chapter-11-protection-5379902)
- 2024-04-01 14:39 UTC [Market Insight] [Dow Falls Over 200 Points; ISM Manufacturing PMI Rises In March](https://www.quantisnow.com/insight/dow-falls-over-200-points-ism-manufacturing-pmi-rises-in-5379799)
- 2024-03-21 17:31 UTC [Market Insight] [12 Health Care Stocks Moving In Thursday's Intraday Session](https://www.quantisnow.com/insight/12-health-care-stocks-moving-in-thursdays-intraday-session-5360730)
- 2024-03-11 20:03 UTC [SEC Form 8-K] [SEC Form 8-K filed by Eiger BioPharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-8-k-filed-by-eiger-biopharmaceuticals-inc-5333926)
- 2024-02-14 21:03 UTC [SEC Schedule 13G] [SEC Form SC 13G/A filed by Eiger BioPharmaceuticals Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13ga-filed-by-eiger-biopharmaceuticals-inc-amendment-5262995)
- 2024-02-14 15:55 UTC [SEC Schedule 13G] [SEC Form SC 13G/A filed by Eiger BioPharmaceuticals Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13ga-filed-by-eiger-biopharmaceuticals-inc-amendment-5260948)
- 2024-01-24 21:59 UTC [SEC Form 8-K] [Eiger BioPharmaceuticals Inc. filed SEC Form 8-K: Leadership Update](https://www.quantisnow.com/insight/eiger-biopharmaceuticals-inc-filed-sec-form-8-k-leadership-update-5205390)
- 2024-01-18 22:52 UTC [Market Chatter] [Eiger, Partner AnGes Receive Approval For Zokinvy (lonafarnib) For Hutchinson-Gilford Progeria Syndrome And Processing-Deficient Progeroid Laminopathies In Japan; Eiger To Get $500K Milestone Payment](https://www.quantisnow.com/insight/eiger-partner-anges-receive-approval-for-zokinvy-lonafarnib-for-hutchinson-gilford-5194687)
- 2024-01-18 22:49 UTC [Eiger and Partner, AnGes, Receive Approval for Zokinvy® (lonafarnib) for Hutchinson- Gilford Progeria Syndrome and Processing-Deficient Progeroid Laminopathies in Japan](https://www.quantisnow.com/insight/eiger-and-partner-anges-receive-approval-for-zokinvy-lonafarnib-for-5194681)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/EIGR
- Earnings history: https://www.quantisnow.com/earnings/EIGR
- Dividend history: https://www.quantisnow.com/dividends/EIGR
- Insider transactions: https://www.quantisnow.com/insiders/EIGR
- Options chain: https://www.quantisnow.com/options/EIGR
- SEC 8-K filings only: https://www.quantisnow.com/company/EIGR/8-k
- RSS and alerts for EIGR: https://www.quantisnow.com/docs/rss-feeds.md